Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie A Jarusiewicz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|December 27, 2005
Effects of diet on the carotenoid pigment and lipid content of Pomacea bridgesii as determined by quantitative high performance thin layer chromatographyJamie A Jarusiewicz, Bernard Fried, Joseph Sherma
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|October 3, 2006
Thin layer chromatographic analysis of glucose and maltose in estivated Biomphalaria glabrata snails and those infected with Schistosoma mansoniJamie A Jarusiewicz, Joseph Sherma, Bernard Fried
ACS Omega|June 6, 2017
Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid LeukemiaJamie A Jarusiewicz, Jae Yoon Jeon, Michele C Connelly, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Gisele Nishiguchi, Satoshi Yoshimura, et al.
Nucleic Acids Research|March 8, 2012
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2Nimanthi Jayathilaka, Aidong Han, Kevin J Gaffney, et al.
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Identification of Small Molecules Exhibiting Oxacillin Synergy through a Novel Assay for Inhibition of <i>vraTSR</i> Expression in Methicillin-Resistant Staphylococcus aureusHyun Lee, Susan Boyle-Vavra, Jinhong Ren, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|December 27, 2005
Effects of diet on the carotenoid pigment and lipid content of Pomacea bridgesii as determined by quantitative high performance thin layer chromatographyJamie A Jarusiewicz, Bernard Fried, Joseph Sherma
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|October 3, 2006
Thin layer chromatographic analysis of glucose and maltose in estivated Biomphalaria glabrata snails and those infected with Schistosoma mansoniJamie A Jarusiewicz, Joseph Sherma, Bernard Fried
ACS Omega|June 6, 2017
Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid LeukemiaJamie A Jarusiewicz, Jae Yoon Jeon, Michele C Connelly, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemiaJun J Yang, Gisele Nishiguchi, Satoshi Yoshimura, et al.
Nucleic Acids Research|March 8, 2012
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2Nimanthi Jayathilaka, Aidong Han, Kevin J Gaffney, et al.
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2019
Identification of Small Molecules Exhibiting Oxacillin Synergy through a Novel Assay for Inhibition of <i>vraTSR</i> Expression in Methicillin-Resistant Staphylococcus aureusHyun Lee, Susan Boyle-Vavra, Jinhong Ren, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
European Journal of Medicinal Chemistry|January 5, 2023
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potentialPeter J Slavish, Maxime G Cuypers, Mary Ashley Rimmer, et al.
Pageof 2